GlassScriptPhysician profile
Maria T Reyes
NPI 1861441776
$840.09
in general payments reported to CMS, 2019-2025
20 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.59 · 2021: $13.49 · 2022: $123 · 2023: $193 · 2024: $249 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $619.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $135.72 | 2021-2024 | |
| Minerva Surgical, INC | $94.20 | 2022-2025 | |
| Astellas Pharma US INC | $71.39 | 2023-2024 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $62.24 | 2024-2025 | Fetal Fibronectin Enzyme Immunoassay, Myosure Tissue Removal Device, Omni Hysteroscope |
| Exeltis, USA INC. | $58.40 | 2019-2024 | Slynd |
| Mayne Pharma Commercial LLC | $57.11 | 2025 | |
| Novo Nordisk INC | $46.96 | 2024-2025 | Wegovy |
| Organon LLC | $45.74 | 2022-2024 | |
| Pfizer INC. | $35.73 | 2023-2024 | |
| Smith+Nephew, INC. | $35.62 | 2019 | |
| Exact Sciences Corporation | $29.33 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $25.84 | 2024 | Ligasure |
| Shield Therapeutics INC | $23.73 | 2023 | Accrufer |
| Millicent US INC | $20.91 | 2025 | Intrarosa, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $20.67 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $18.85 | 2019 | |
| Sage Therapeutics, LLC | $16.99 | 2025 | Zurzuvae |
| Lilly USA, LLC | $14.61 | 2025 | Zepbound, Mounjaro |
| Pacira Pharmaceuticals Incorporated | $14.03 | 2019 | |
| Avion Pharmaceuticals | $12.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.